ABSI - Conference and earnings call announcements

VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference (Boston, MA)Fireside chat on Tuesday, November 10th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time 2026 Jefferies Global Healthcare Conference (London, England)Fireside chat on Wednesday, November 18th at 3:00 p.m. Greenwich Mean Time / 10:00 a.m. Eastern Time 9th Annual Evercore Healthcare Conference (Coral Gables, FL)Fireside c

VANCOUVER, Wash. and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: H.C. Wainwright 28th Annual Global Investment Conference (New York, NY) Fireside chat on Tuesday, September 15th at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time Morgan Stanley 24th Annual Global Healthcare Conference (New York, NY) Fireside chat on Wednesday, September 16th at 7:45 a.m. Eastern Time / 4:45 a.m. Pacific Time Interested parties may access live and archived webcasts o

VANCOUVER, Wash. and NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences: 2026 Jefferies Global Healthcare Conference (New York, NY)Presentation on Wednesday, June 3rd at 7:35 a.m. Eastern Time / 4:35 a.m. Pacific Time Goldman Sachs 47th Annual Global Healthcare Conference (Miami, FL)Presentation on Tuesday, June 9th at 3:20 p.m. Eastern Time / 12:20 p.m. Pacific Time Interested parties may access live and archived webcasts of the presentations on the company's

VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the upcoming 25th Annual Needham Virtual Healthcare Conference. Absci management is scheduled to participate in a fireside chat on Thursday, April 16th at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is advancing the future of drug discovery with generative design to create better bio

VANCOUVER, Wash. and NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences: TD Cowen 46th Annual Health Care Conference (Boston, MA)Fireside chat on Monday, March 2 at 9:10 a.m. Eastern Time / 6:10 a.m. Pacific Time, and hosting 1x1 meetings Leerink Partners 2026 Global Healthcare Conference (Miami, FL)Fireside chat on Monday, March 9 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings Jefferies 2026 Biotech on the Beach Summit (Miami, FL)Hosting

VANCOUVER, Wash. and NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Absci management is scheduled to present on Wednesday, January 14th at 3:45 p.m. Pacific Time (6:45 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is advancing the future of drug discovery with generative design to create bett

VANCOUVER, Wash. and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim Securities 2nd Annual Healthcare Innovation Conference (Boston, MA)Fireside chat on Monday, November 10 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings UBS Global Healthcare Conference (Palm Beach Gardens, FL)Hosting 1x1 meetings on Tuesday, November 11 Jefferies Global Healthcare Conference (London, UK)Presentation on Tuesday, November 18 at 9:30 a.m. Greenwich Me

Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadership Phase 1/2a trial now expected to begin in December 2025, ahead of prior guidance VANCOUVER, Wash. and NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Absci (NASDAQ:ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will host a virtual seminar on December 11, 2025 at 10:00am ET focused on the company's ABS-201 (anti-PRLR) program for androgenetic alopecia. Additionally, Absci now expects to initiate the Phase 1/2a trial for this program in early December, ahead of prior guidance for early 2026, with an interim efficac

VANCOUVER, Wash. and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences: 2025 Wells Fargo Healthcare Conference (Boston, MA) Hosting 1x1 meetings on Wednesday, September 3 Morgan Stanley 23rd Annual Global Healthcare Conference (New York, NY) Fireside chat on Monday, September 8 at 3:20 p.m. Eastern Time / 12:20 p.m. Pacific Time, and hosting 1x1 meetings H.C. Wainwright 27th Annual Global Investment Conference (New York, NY) Fireside chat on Tuesday, Se

VANCOUVER, Wash. and NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design, today announced the company will be participating in the following upcoming investor conferences. Jefferies Global Healthcare Conference (New York, NY)Presentation on Thursday, June 5 at 2:00 p.m. Eastern Time / 11:00 a.m. Pacific Time Goldman Sachs 46th Annual Global Healthcare Conference (Miami, FL)Presentation on Monday, June 9 at 8:40 a.m. Eastern Time / 5:40 a.m. Pacific Time TD Cowen 4th Annual Tools/Dx Revolution (Dana Point, CA)June 22-25; Interested parties may contact their TD Cow

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual ConferenceFireside chat on Wednesday, April 2 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time 24th Annual Needham Virtual Healthcare ConferenceFireside chat on Tuesday, April 8 at 3:45 p.m. Eastern Time / 12:45 p.m. Pacific Time Interested parties may access live and archived webcasts of the fireside chat sessions on the company's

VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming virtual KeyBanc Capital Markets Healthcare Forum. Absci management is scheduled to participate in a fireside chat on Wednesday, March 19th at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients,

VANCOUVER, Wash. and NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, MA. Absci management is scheduled to participate in a fireside chat on Monday, March 3rd at 3:10 p.m. Eastern Time (12:10 p.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for pati

VANCOUVER, Wash. and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Guggenheim Securities SMID Cap Biotech Conference in New York, NY. Absci management is scheduled to participate in a fireside chat on Wednesday, February 5th at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biol

VANCOUVER, Wash. and NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Absci management is scheduled to present on Wednesday, January 15th at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologi

VANCOUVER, Wash. and NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 36th Annual Piper Sandler Healthcare Conference in New York, NY. Absci's Founder & CEO Sean McClain is scheduled to participate in a panel discussion titled "The Promise of AI in Drug Development" on Thursday, December 5th at 2:00 p.m. Eastern Time. Interested parties may contact their Piper Sandler representative to request registration details for this live event. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab te

VANCOUVER, Wash. and NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. Truist Securities BioPharma Symposium (New York, NY)Hosting 1x1 meetings on Thursday, November 7 Guggenheim Securities Inaugural Healthcare Innovation Conference (Boston, MA)Fireside chat on Monday, November 11 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings UBS Global Healthcare Conference (Rancho Palos Verdes, CA)Fireside chat on Wednesday, November 13 at 10:15 a.m. Eastern Time / 7:15 a.m. Pacific Time, and hosti

VANCOUVER, Wash. and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. Morgan Stanley 22nd Annual Global Healthcare ConferenceFireside chat on Thursday, September 5th at 5:35 p.m. Eastern Time Citi 2024 Global TMT Conference Fireside chat on Friday, September 6th at 8:20 a.m. Eastern Time H.C. Wainwright 26th Annual Global Investment ConferenceFireside chat on Tuesday, September 10th at 12:00 p.m. Eastern Time Interested parties may access live and archived webcasts of these events on the company's investo

VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3rd Annual Life Sciences AI Summit on June 26-27 in New York, NY. Interested parties may contact their Morgan Stanley representative to request registration details for this live event. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the pr

VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL. Absci management is scheduled to present on Monday, June 10th at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

VANCOUVER, Wash. and NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 23rd Annual Needham Virtual Healthcare Conference. Absci management is scheduled to present on Monday, April 8th at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated D

VANCOUVER, Wash. and NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. TD Cowen 44th Annual Health Care Conference in Boston, MA Fireside chat on Monday, March 4th at 2:10 p.m. Eastern Time / 11:10 a.m. Pacific Time KeyBanc Capital Markets Emerging Technology Summit in San Francisco, CA Fireside chat on Wednesday, March 6th at 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual) Fireside chat on Thursday, March 7th KeyBanc Capital Markets 4th A

VANCOUVER, Wash. and NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming 26th Annual Needham Growth Conference. Absci management is scheduled to present on Friday, January 19th at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug

VANCOUVER, Wash. and NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Absci management is scheduled to present on Thursday, January 11th at 10:30 a.m. Pacific Time (1:30 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients,

VANCOUVER, Wash. and NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, NY. Absci management is scheduled to present on Wednesday, November 29th at 10:50 a.m. Eastern Time (7:50 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Dru

VANCOUVER, Wash. and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences in New York, NY. Truist Securities 2023 BioPharma SymposiumHosting 1x1 meetings on Wednesday, November 8th Stifel 2023 Healthcare ConferenceParticipating in a fireside chat on Wednesday, November 15th at 9:45 a.m. Eastern Time and hosting 1x1 meetings Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumParticipating in a fireside chat on Thursday, November 16th at 9:00 a.m. Eastern Time and hosting 1x1 meetings Interes

VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. Wainwright 25th Annual Global Investment ConferenceFireside chat on Monday, September 11th at 2:00 p.m. Eastern Time Morgan Stanley 21st Annual Global Healthcare ConferenceFireside chat on Wednesday, September 13th at 4:55 p.m. Eastern Time 2023 Cantor Fitzgerald Global Healthcare ConferenceFireside chat on Tuesday, September 26th at 8:10 a.m. Eastern Time Interested parties may access live and archived webcasts of these events on the

VANCOUVER, Wash. and NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA. Absci management is scheduled to participate in a panel discussion titled "Generative AI & Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine" on Tuesday August 15th at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company

VANCOUVER, Wash. and NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Canaccord Genuity 43rd Annual Growth Conference in Boston, MA. Absci management is scheduled to participate in a panel discussion titled "The role of AI in life sciences research, drug discovery and clinical diagnostics" on Wednesday, August 9th at 2:00 p.m. Eastern Time. Interested parties may contact their Canaccord Genuity representative to request registration details for this live event. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet l

VANCOUVER, Wash. and NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 2nd Annual Biotechnology AI Summit in New York, NY. Absci management is scheduled to participate in a panel discussion on Thursday June 29th. Interested parties may contact their Morgan Stanley representative to request registration details for this live event. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the pote

VANCOUVER, Wash. and NEW YORK, April 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 22nd Annual Needham Virtual Healthcare Conference. Absci management is scheduled to present on Thursday, April 20th at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platf

VANCOUVER, Wash. and NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation. Absci's management is scheduled to participate in a panel discussion and a fireside chat, the details of which are below: Panel: How to translate insights from proteomics and advances in AI into drug discovery and innovation?Thursday April 6th at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time Fireside ChatThursday April 6th at 12:30 p.m. Pacific Time / 3:30 p.

VANCOUVER, Wash. and NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming KeyBanc Capital Markets Life Sciences & MedTech Investor Forum. Absci management is scheduled to participate in a fireside chat on Tuesday March 21st at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). Interested parties may access a live and archived webcast on the company's investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients,

VANCOUVER, Wash. and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual Cowen Health Care Conference. Absci's management is scheduled to participate in a panel discussion and a fireside chat, the details of which are below. SynBio & AI Driven Drug Discovery PanelMonday March 6th at 1:40 p.m. Pacific Time / 4:40 p.m. Eastern Time Fireside ChatWednesday March 8th at 9:50 a.m. Pacific Time / 12:50 p.m. Eastern Time Interested parties may access a live and archived webcast of both sessions on the company's investor relations website at: investors.abs

VANCOUVER, Wash. and NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Absci management is scheduled to present on Tuesday, January 10th at 5:15 p.m. Pacific Time (8:15 p.m. Eastern Time). This presentation time has been updated from a previous announcement and reflects the current schedule. Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the drug and target discovery comp

VANCOUVER, Wash. and NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Absci management is scheduled to present on Thursday, January 12th at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

VANCOUVER, Wash. and NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Berenberg Discover AI Seminar in New York, NY. Absci management is scheduled to participate in a fireside chat on Tuesday, November 29th at 10:00 a.m. Eastern Time. To attend this live event, please contact your Berenberg representative with interest. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ platform to identify novel drug targets, di

VANCOUVER, Wash. and NEW YORK, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York, NY. Absci management is scheduled to present on Thursday, December 1st at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our In

VANCOUVER, Wash. and NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), leaders in the protein drug creation revolution harnessing generative AI and scalable biological data to design better therapeutics, faster, today announced the company will be participating in the upcoming Stifel Healthcare Conference in New York, NY. Absci management is scheduled to participate in a fireside chat on Wednesday, November 16th at 4:10 p.m. Eastern Time (1:10 p.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the drug and target discovery co

VANCOUVER, Wash. and NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), leaders in the protein drug creation revolution harnessing generative AI and scalable biological data to design better therapeutics, faster, today announced the company will be participating in the upcoming Credit Suisse Annual Healthcare Conference in Rancho Palos Verdes, CA. Absci management is scheduled to participate in a fireside chat on Thursday, November 10th at 9:10 a.m. Pacific Time (12:10 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the dru

VANCOUVER, Wash. and NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the upcoming Morgan Stanley Annual Healthcare Conference in New York, NY. Absci management is scheduled to participate in a fireside chat on Wednesday, September 14th at 4:05 p.m. Eastern Time (1:05 p.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the dru

VANCOUVER, Wash. and NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Absci management is scheduled to participate in a fireside chat on Wednesday, August 31st at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is th

VANCOUVER, Wash. and NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit Conference in Dana Point, CA. Absci management is scheduled to participate in a fireside chat on Tuesday, August 9th at 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci

VANCOUVER, Wash. and NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event. Absci, as a leader in large molecule AI drug discovery, is scheduled to participate in the Drug R&D and Development panel on Wednesday, July 27th at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time). To virtually attend this live event, please contact your SVB Securities representative with interest.

VANCOUVER, Wash., April 28, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference held in Las Vegas, NV. Absci's management is scheduled to present on Wednesday, May 11th at 5:20 p.m. Pacific Time (8:20 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company's investor relations website at: investors.absci.com. About Absci Absci is the drug and target discovery company harnessing

VANCOUVER, Wash., March 16, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a drug and target discovery company harnessing deep learning, AI and synthetic biology to expand the therapeutic potential of proteins, today announced that Absci Lead AI Scientist Joshua Meier will be presenting at NVIDIA GTC. The session is scheduled for March 22, 2022 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time. Interested parties may attend the virtual presentation by registering for free at https://www.nvidia.com/gtc/. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Int

VANCOUVER, Wash., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the following investor conferences. Truist Life Sciences AI Symposium – Biotech & ToolsPanel Discussion on Tuesday, March 1st at 7:10 a.m. Pacific Time / 10:10 a.m. Eastern TimeInterested parties may view the Symposium panels by registering through Truist's showcase website at https://truist-securities-2022-ai-symposium-biotech-tools.videoshowcase.net/login Cowen 42nd Annual Health Care ConferenceFiresid

VANCOUVER, Wash., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Absci's management is scheduled to present on Tuesday, February 15th at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time. To listen to the live event, please contact your BTIG representative with interest. About Absci Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expan

VANCOUVER, Wash., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Absci's management is scheduled to present on Monday, January 10th at 12:45 p.m. Pacific Time / 3:45 p.m. Eastern Time. This presentation time has been updated from a previous announcement and reflects the current schedule. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website

VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the H.C. Wainwright BIOCONNECT Virtual Conference. Absci's management is scheduled to present on Monday, January 10th at 4:00 a.m. Pacific Time / 7:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website via www.absci.com. About Absci Absci is the drug and target discovery company harnessing deep learning and synthetic

VANCOUVER, Wash., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Absci's management is scheduled to present on Monday, January 10th at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website via www.absci.com. About Absci Absci is the drug and target discovery company harnessing deep learning

VANCOUVER, Wash., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will be participating virtually in the following investor conferences. Credit Suisse 30th Annual Healthcare ConferenceFireside Chat on Tuesday, November 9th at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern TimeStifel 2021 Virtual Healthcare ConferenceFireside Chat on Tuesday, November 16th at 1:40 p.m. Pacific Time / 4:40 p.m. Eastern Time Interested parties may access live and archived webcasts of the presentations on the "Investors" section of the com

VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BofA Securities 2021 Tech Solutions for Drug Discovery Conference. Absci's management is scheduled to present on Monday, September 20 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at www.absci.com. About Absci Absci is the drug and target discovery comp